Eckert & Ziegler forms joint venture with TCL Healthcare for tumor irradiation devices in China

Eckert & Ziegler AG and TCL Healthcare Equipment (Shanghai) Co., Ltd. formed a joint venture, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd., to develop, produce and distribute advanced tumor irradiation devices in China. The JV is held 49% by EZAG and 51% by TCL.

“We look forward to advancing brachytherapy with a strong partner in China.”eqs-news.com

• 1 source
• eqs-news.comEckert & Ziegler forms joint venture for tumor irradiation devices in China | Corporate - EQS NewsAug 1, 2019

Summarized from public sources; check the original articles before acting on it.